ImmuCell Corporation (ICCC) Total liabilities 2017–2025
ImmuCell Corporation (ICCC) total liabilities at each fiscal year-end, per SEC filings.
$15.5MFY2025 · since FY2017: $10.7M → $15.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.5M | -12.0% |
| FY2024 | $17.6M | -6.6% |
| FY2023 | $18.8M | +29.9% |
| FY2022 | $14.5M | +21.8% |
| FY2021 | $11.9M | -1.6% |
| FY2020 | $12.1M | +24.6% |
| FY2019 | $9.7M | -11.7% |
| FY2018 | $11.0M | +2.6% |
| FY2017 | $10.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice